borderline diabetics
Conditions
Interventions
Receive 8 g / day of Chlorella for 12 weeks.
Receive 8 g / day of Placebo(lactose) for 12 weeks.
Sponsors
CPCC Inc.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Healthy adult Japanese males. 2. HbA1c (NGSP values) concentration; between 6.0% and 6.5% at the screening. 3. Written informed is required.
Exclusion criteria
Exclusion criteria: 1. These having Food for Specified Health Uses (FOSHU) and/or health food. 2. These prescreened medicine. 3. These having a history of serious diseases in metabolic and/or endocrine system 4. Those that have extremely disheveled lifestyle and/or dietary habits. 5. Heavy alcohol drinker. 6. Those that are considered to be ineligible to participate to this test due to their abnormality at the screening test. 7. Those having an allergy to food and/or drug 8. Those participating in another trial or other investigational. 9. Those that are judged not applicable to this study by physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c,HDL-C,LDL-C,TCHL,IL-6 | — |
Secondary
| Measure | Time frame |
|---|---|
| Gene expression( microarray and qRT-PCR ) | — |
Countries
Japan
Contacts
Public ContactMichie Kobayashi
DNA Chip Research Inc. Research & Development Dept.
Outcome results
None listed